Pathfinders in Biopharma Podcast Por RBC Capital Markets arte de portada

Pathfinders in Biopharma

Pathfinders in Biopharma

De: RBC Capital Markets
Escúchala gratis

Acerca de esta escucha

 Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.Copyright 2025 RBC Capital Markets Economía Finanzas Personales Política y Gobierno
Episodios
  • PTC Therapeutics: Building a durable company to benefit patients

    PTC Therapeutics: Building a durable company to benefit patients
    Jun 27 2025

    A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.
    Más Menos
    14 m
  • BioAge is translating insights from the science of aging into new medicines

    BioAge is translating insights from the science of aging into new medicines
    May 29 2025

    Scott Neidhold, Director in RBC’s Life Sciences Investment Banking Practice, sits down with Kristen Fortney, CEO and Co-Founder of BioAge, for a deep dive into how her company is turning cutting-edge aging science into real therapeutic breakthroughs — and what it means for the future of biopharma.
    Más Menos
    20 m
  • Uncertainty reigns, but opportunity persists for biotech’s 2025

    Uncertainty reigns, but opportunity persists for biotech’s 2025
    Feb 7 2025

    Universal wisdom had it that a Republican sweep in the U.S. election would favor biotech. Appointments to the new administration’s healthcare leadership make that far less certain. What effect will this and other factors have on the industry in 2025, and where are the breakthroughs likely to be found? Brian Abrahams, Head of Global Healthcare Research at RBC Capital Markets, looks ahead with in this episode of Pathfinders in Biotech.
    Más Menos
    9 m
Todavía no hay opiniones